We are live on ! Find out more
AP

AtonRa Partners Portfolio holdings

AUM $50.2M
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-10.66%
1 Year Est. Return
+47.76%
3 Year Est. Return
+48.32%
5 Year Est. Return
10 Year Est. Return
AUM
$47.7M
AUM Growth
-$16.9M
Cap. Flow
-$8.49M
Cap. Flow %
-17.82%
Top 10 Hldgs %
16.09%
Holding
128
New
12
Increased
4
Reduced
108
Closed
4

Top Buys

Rank Stock Value
1
TOST icon
Toast
TOST
+$437K
2
INTA icon
Intapp
INTA
+$434K
3
RELY icon
Remitly
RELY
+$420K
4
AXSM icon
Axsome Therapeutics
AXSM
+$387K
5
ANSS
Ansys
ANSS
+$262K

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$1.25M
2
LEGN icon
Legend Biotech
LEGN
+$491K
3
PLTR icon
Palantir
PLTR
+$406K
4
INTU icon
Intuit
INTU
+$387K
5
NVDA icon
NVIDIA
NVDA
+$379K

Sector Composition

Rank Sector Weight
1 Technology 52.33%
2 Healthcare 35.94%
3 Industrials 5.08%
4 Financials 4.01%
5 Communication Services 2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPLK
76
DELISTED
Splunk Inc
SPLK
$304K 0.64%
2,076
-639
-24% -$72.4K
ENPH icon
77
Enphase Energy
ENPH
$4.84B
$302K 0.63%
2,512
-163
-6% -$23.2K
NARI
78
DELISTED
Inari Medical, Inc. Common Stock
NARI
$299K 0.63%
4,577
-110
-2% -$6.92K
GH icon
79
Guardant Health
GH
$19.5B
$289K 0.61%
9,756
-745
-7% -$26.2K
PL icon
80
Planet Labs
PL
$7.3B
$286K 0.6%
110,055
-32,529
-23% -$103K
MRVL icon
81
Marvell Technology
MRVL
$174B
$281K 0.59%
5,195
-4,617
-47% -$273K
TENB icon
82
Tenable Holdings
TENB
$3.56B
$281K 0.59%
6,268
-1,923
-23% -$86.4K
MRNA icon
83
Moderna
MRNA
$21.5B
$281K 0.59%
2,717
-570
-17% -$63.6K
VRNS icon
84
Varonis Systems
VRNS
$5.25B
$270K 0.57%
8,853
-2,604
-23% -$76.9K
ENV
85
DELISTED
ENVESTNET, INC.
ENV
$270K 0.57%
6,128
-1,495
-20% -$82.1K
QLYS icon
86
Qualys
QLYS
$4.84B
$267K 0.56%
1,748
-529
-23% -$76.1K
KYMR icon
87
Kymera Therapeutics
KYMR
$9.1B
$266K 0.56%
19,172
-2,775
-13% -$55.8K
TRMB icon
88
Trimble
TRMB
$12.3B
$265K 0.56%
4,928
-1,751
-26% -$92.8K
NTLA icon
89
Intellia Therapeutics
NTLA
$1.5B
$265K 0.56%
8,370
-1,804
-18% -$70K
FICO icon
90
Fair Isaac
FICO
$28.7B
$264K 0.55%
304
-65
-18% -$55.8K
TMO icon
91
Thermo Fisher Scientific
TMO
$211B
$263K 0.55%
520
-12
-2% -$6.39K
RPD icon
92
Rapid7
RPD
$634M
$261K 0.55%
5,704
-1,664
-23% -$76.8K
A icon
93
Agilent Technologies
A
$39.1B
$260K 0.55%
2,328
-51
-2% -$6.11K
SOFI icon
94
SoFi Technologies
SOFI
$21.1B
$259K 0.54%
32,419
-7,389
-19% -$65K
SMAR
95
DELISTED
Smartsheet Inc.
SMAR
$249K 0.52%
6,163
-1,475
-19% -$60.5K
OM icon
96
Outset Medical
OM
$74.9M
$248K 0.52%
1,519
-11
-0.7% -$2.6K
ANSS
97
DELISTED
Ansys
ANSS
$246K 0.52%
+828
New +$262K
ABT icon
98
Abbott
ABT
$180B
$245K 0.51%
2,533
-101
-4% -$10.6K
FTNT icon
99
Fortinet
FTNT
$112B
$245K 0.51%
4,169
-1,304
-24% -$86.3K
LHX icon
100
L3Harris
LHX
$55.9B
$244K 0.51%
1,400
-432
-24% -$79.5K

Similar funds

AtonRa Partners's Q3 2023 Portfolio in Review

As of Q3 2023, AtonRa Partners held 128 positions worth $47.7M, down 26% from $64.6M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

AtonRa Partners withdrew a net $8.49M in Q3 2023, closing 4 positions and reducing 108 holdings. Its most notable exit was PayPal, an estimated $1.25M position sold in full.

By sector, the portfolio is most concentrated in Technology at 52% of assets, up from 48% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, AtonRa Partners opened a new position in Toast worth $377K.

  • AtonRa Partners's largest Q3 2023 buy was Toast: 20,116 shares worth $377K.
  • AtonRa Partners added most to CrowdStrike in Q3 2023, an estimated $146K increase.
  • AtonRa Partners's biggest Q3 2023 reduction was Legend Biotech, cutting an estimated $491K.
  • AtonRa Partners fully exited PayPal in Q3 2023, selling an estimated $1.25M.
  • AtonRa Partners's ten largest holdings make up 16% of its $47.7M portfolio in Q3 2023.
  • AtonRa Partners opened 12 new positions and closed 4 in Q3 2023.
  • AtonRa Partners's portfolio value fell 26% quarter-over-quarter to $47.7M.

Based on AtonRa Partners's 13F filing for Q3 2023, filed 25 Oct 2023.